Insights into Platelet Biogenesis: Epigenetic Programs Essential for Efficient Platelet Production

Strategic Insights -

Recent research published in Nature Communications has shed light on the epigenetic programs essential for platelet biogenesis. The study, conducted at the University of Texas MD Anderson Cancer Center, focused on the roles of histone lysine methyltransferases MLL3 and MLL4 in regulating gene expression during platelet production. The findings suggest that MLL3 and MLL4 play critical roles in ensuring the efficient production of platelets, and their absence leads to abnormal platelet formation and clearance.

Key Takeaways:

  • The study highlights the importance of epigenetic programs in regulating gene expression during platelet production, with MLL3 and MLL4 acting as key regulators.
  • MLL3 and MLL4 are responsible for depositing H3K4me1 histone marks at enhancers, which is essential for normal megakaryocyte function and platelet production.
  • Loss of PTIP, a co-factor of MLL3/4, leads to decreased platelet numbers in mice, indicating the importance of these complexes in regulating platelet production.
  • MLL3/4 double-deficient mice develop macrothrombocytopenia, characterized by preactivated and pro-apoptotic platelets, leading to their rapid clearance from the circulation.
  • The expression of genes responsible for normal megakaryocyte function and platelet production is altered in MLL3/4-deficient megakaryocytes, partly due to impaired enhancer functions associated with these genes.
  • The study provides insights into the epigenetic programs essential for platelet biogenesis and highlights the importance of regulating gene expression during platelet production.

Statistics:

  • 16(1): The volume and issue number of the Nature Communications publication.
  • August 5, 2025: The date of the study publication.
  • 2024-2025: The time period during which the study was conducted.

Sources:

  • "Histone Lysine Methyltransferases Mll3 and Mll4 Direct Gene Expression To Produce Platelets Efficiently." Nature Communications 16(1). doi: 10.1038/s41467-025-04083-9.
  • University of Texas MD Anderson Cancer Center, Dept. of Epigenetics and Molecular Carcinogenesis, Houston, TX 77030, United States.
  • Additional authors: Guozhen Gao, Josimar Dornelas Moreira, Kevin Lin, Taiping Chen, Yue Lu, Prosun Das, and Kai Ge.
  • Funding: U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) - USA, Cancer Prevention & Research Institute of Texas.